Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8VRS

Mucin 16 peptide fused to MBP in complex with 4H11-scFv antibody

8VRS の概要
エントリーDOI10.2210/pdb8vrs/pdb
関連するPDBエントリー8VRR
分子名称Maltose/maltodextrin-binding periplasmic protein,Mucin-16, 4H11 scFv chain (3 entities in total)
機能のキーワードantibody complex epitope cancer therapy immunotherapy mucins, oncoprotein, oncoprotein-immune system complex, oncoprotein/immune system
由来する生物種Escherichia coli
詳細
タンパク質・核酸の鎖数4
化学式量合計142226.87
構造登録者
Lee, K.,Perry, K.,Yeku, O.O.,Spriggs, D.R. (登録日: 2024-01-22, 公開日: 2024-04-03, 最終更新日: 2024-11-06)
主引用文献Lee, K.,Perry, K.,Xu, M.,Veillard, I.,Kumar, R.,Rao, T.D.,Rueda, B.R.,Spriggs, D.R.,Yeku, O.O.
Structural basis for antibody recognition of the proximal MUC16 ectodomain.
J Ovarian Res, 17:41-41, 2024
Cited by
PubMed Abstract: Mucin 16 (MUC16) overexpression is linked with cancer progression, metastasis, and therapy resistance in high grade serous ovarian cancer and other malignancies. The cleavage of MUC16 forms independent bimodular fragments, the shed tandem repeat sequence which circulates as a protein bearing the ovarian cancer biomarker (CA125) and a proximal membrane-bound component which is critical in MUC16 oncogenic behavior. A humanized, high affinity antibody targeting the proximal ectodomain represents a potential therapeutic agent against MUC16 with lower antigenic potential and restricted human tissue expression.
PubMed: 38374055
DOI: 10.1186/s13048-024-01373-9
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.47 Å)
構造検証レポート
Validation report summary of 8vrs
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon